Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Biotegy Corporation Featured in Report Published by The Icons

By: Newsfile

Taipei, Taiwan--(Newsfile Corp. - September 14, 2025) - Biotegy Corporation, founded by Dr. Hsu-Wei Fang has recently been featured in a report by The Icons, highlighting a series of important milestones that strengthen Taiwan's position in the global medical technology landscape. 

Cannot view this image? Visit: https://images.newsfilecorp.com/files/11580/266155_5d8696ece470cb4f_001.jpg

Dr. Hsu-Wei Fang leads his team in turning research into medical devices that directly address clinical needs. From material design to regulatory validation, Biotegy Corporation's role is to streamline processes, reduce risks and ensure that outcomes genuinely reach the clinical setting. (Photo: Biotegy Corporation)

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11580/266155_5d8696ece470cb4f_001full.jpg

Biotegy first drew attention for achieving Class II certification for barbed sutures and lifting threads in just over two years, far faster than the typical approval timeline. This achievement demonstrated that locally developed innovation in Taiwan can successfully pass the world's most rigorous scrutiny and enter the market on its own merits.

The company soon advanced into higher-level categories, securing two Class III medical device certifications within three years-one for a polylactic acid (PLA) dermal filler and another for a modified-starch haemostatic agent. Both products underwent extensive clinical trials and multi-stage regulatory review. The PLA filler has since been certified internationally and introduced to overseas markets, confirming Biotegy's capability to deliver products that meet global demand.

In September 2025, Biotegy made its international debut at the Thailand International Medical Exhibition, one of Asia's leading industry platforms. The company presented its degradable polymer platform and met with distributors, investors, and potential partners from around the world. The exhibition marked a decisive step in Biotegy's global expansion and highlighted Taiwan's growing presence in advanced healthcare solutions.

The company's rapid progress is seen as a reflection of Taiwan's transition from a support role in global supply chains to becoming a source of original innovation. By earning high-level certifications, expanding distribution abroad, and gaining visibility through international exhibitions, Biotegy has shown that "Made in Taiwan" medical technology can compete directly at the highest levels of the industry.

Commenting on the company's mission, Dr. Hsu-Wei Fang stated: "From the beginning, our goal has been clear: research must not remain in the laboratory-it must reach patients. By achieving certifications and expanding into global markets, we are proving that Taiwan can stand on its own capabilities and deliver world-class medical technology."

With its expanding international footprint, Biotegy continues to strengthen Taiwan's position in global healthcare. The company's achievements provide a signal of how domestic innovation can evolve into internationally recognised solutions, contributing to both industry growth and patient outcomes worldwide.

Media Contact
Hsu-Wei Fang
Biotegy Corporation
Email: info@biotegy.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266155

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.